Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Neoplasms 10Head and Neck Neoplasms 8Carcinoma, Squamous Cell 8Lung Neoplasms 7Leukemia, Myeloid, Acute 7Glioblastoma 7Colorectal Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 6Recurrence 5Pancreatic Neoplasms 5Melanoma 5Leukemia 5Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Fallopian Tube Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Rectal Neoplasms 3Lymphoma, Follicular 3Colonic Neoplasms 3Brain Neoplasms 3Treatment 2Sarcoma 2Pleural Effusion, Malignant 2Pharyngeal Neoplasms 2

Interventions

fludarabine 1Thiotepa 1Muromonab-CD3 1Melphalan 1Immunotherapy 1Drug Therapy 1Cyclophosphamide 1Antibodies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Histiocytosis × Drug Therapy × Clear all
NCT00145626 2017-06-19

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Completed
40 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡